NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018

J Natl Compr Canc Netw. 2018 Oct;16(10):1171-1182. doi: 10.6004/jnccn.2018.0079.

Abstract

The NCCN Guidelines for Small Cell Lung Cancer (SCLC) address all aspects of disease management. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for SCLC regarding immunotherapy, systemic therapy, and radiation therapy. For the 2018 update, new sections were added on "Signs and Symptoms of SCLC" and "Principles of Pathologic Review."

Publication types

  • Practice Guideline
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents, Immunological / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Brain Neoplasms / prevention & control*
  • Brain Neoplasms / secondary
  • Chemoradiotherapy / methods
  • Chemoradiotherapy / standards
  • Cranial Irradiation / methods
  • Cranial Irradiation / standards
  • Dose-Response Relationship, Radiation
  • Humans
  • Lung Neoplasms / diagnosis
  • Lung Neoplasms / pathology
  • Lung Neoplasms / therapy*
  • Medical Oncology / methods
  • Medical Oncology / standards*
  • Neoplasm Staging
  • Pneumonectomy / methods
  • Pneumonectomy / standards
  • Radiotherapy Dosage
  • Randomized Controlled Trials as Topic
  • Small Cell Lung Carcinoma / diagnosis
  • Small Cell Lung Carcinoma / mortality
  • Small Cell Lung Carcinoma / secondary
  • Small Cell Lung Carcinoma / therapy*
  • Societies, Medical / standards
  • Survival Analysis
  • Treatment Outcome
  • United States

Substances

  • Antineoplastic Agents, Immunological